Skip to main content
SpringerLink
Log in

Computer-aided prediction of prodrug activity using the pass system

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. D. A. Filimonov, V. V. Poroikov, E. I. Karaicheva, et al.,Éksp. Klin. Farmakol.,58(2), 56–62 (1995).

    Google Scholar 

  2. D. A. Filimonov and V. V. Poroikov,Bioactive Compound Design: Possibilities for Industrial Use, BIOS Scientific Publishers (1996), pp. 47–56.

  3. V. V. Poroikov and D. A. Filimonov,QSAR and Molecular Modeling: Concepts, Computational Tools and Biological Applications, Prous Science Publishers, Barcelona (1996) p. 49–50.

    Google Scholar 

  4. Prodrugs: Chemical Aspect, in:Itogi Nauki Tekhn., Ser. Org. Khim., Vol 19, VINITI, Moscow (1991).

  5. V. M. Vrudhula, H. P. Svensson, and P. D. Senter,J. Med. Chem.,38(8), 1380–1385 (1995).

    Google Scholar 

  6. D. Bonnaffe, B. Dupraz, J. Ughetto-Monfrin, et al.,Nucleosides Nucleotides,14(3–5), 783–787 (1995).

    Google Scholar 

  7. L. El Kihel, P. M. Loiseau, J. Bourass, et al.,Arzneim.-Forsch.,44(11), 1259–1264 (1994).

    Google Scholar 

  8. J. C. Roberts, K. E. Koch, S. R. Detrick, et al..Radiat. Res.,143(2), 203–213 (1995).

    Google Scholar 

  9. G. R. Pettit, C. Temple, V. L. Narayanan, et al.,Anti-Cancer Drug Design,10(4), 299–309 (1995).

    Google Scholar 

  10. J. P. Burkhart, J. R. Koehl, S. Mehdi, et al.,J. Med. Chem.,38(2), 223–233 (1995).

    Google Scholar 

  11. G. K. E. Scriba, D. M. Lambert, and J. H. Poupaert,J. Pharm. Sci.,84(3), 300–302 (1995).

    Google Scholar 

  12. T. Kawaguchi, H. Sakairi, S. Kimura, et al.,Chem. Pharm. Bull.,43(3), 501–504 (1995).

    Google Scholar 

  13. F. M. Menger, Y. Guo, and A. S. Lee,Bioconjugate Chem.,5(2), 162–166 (1994).

    Google Scholar 

  14. K.-Y. Moon, F. N. Shirota, N. Baturay, et al.,J. Med. Chem.,38(5), 848–851 (1995).

    Google Scholar 

  15. X. Guo, M. Lernertung, H. X. Chen, et al.,Biochem. Pharmacol.,49(8), 1111–1116 (1995).

    Google Scholar 

  16. A.-S. Charvet, M. Camplo, and P. Faury,J. Med. Chem.,37(14), 2216–2223 (1994).

    Google Scholar 

  17. K. Shanmuganathan, T. Koudiakova, S. Nampalli, et al.,J. Med. Chem.,37(6), 821–827 (1994).

    Google Scholar 

  18. T. C. Burnette, J. A. Harrington, J. E. Reardon, et al.,J. Biol. Chem.,270(26), 15827–15831 (1995).

    Google Scholar 

  19. J. H. Bateson, G. Burton, S. C. M. Fell, et al.,J. Antibiot.,47(2), 253–256 (1994).

    Google Scholar 

  20. S. K. Davidsen, J. B. Summers, D. H. Albert, et al.,J. Med. Chem.,37(26), 4423–4429 (1994).

    Google Scholar 

  21. T. J. Carty, A. Marfat, and P. F. Moore,Agents Actions,39(3–4), 157–165 (1993).

    Google Scholar 

  22. J. Takata, Y. Karube, Y. Nagata, et al.,J. Pharm. Sci.,84(1), 96–100 (1995).

    Google Scholar 

  23. J. Patel, M. J. Katovich, K. B. Sloan, et al.,J. Pharm. Sci.,84(2), 174–178 (1995).

    Google Scholar 

  24. R. Kumar, L. Wang, L. I. Wiebe, et al.,J. Med. Chem.,37(25), 4297–4306 (1994).

    Google Scholar 

  25. H. Ford, Jr., M. A. Siddiqui, et al.,J. Med. Chem.,38(7), 1189–1195 (1995).

    Google Scholar 

  26. C. Desseaux, C. Gouyette, Y. Henin, et al.,Tetrahedron,51(24), 6739–6756 (1995).

    Google Scholar 

  27. R. B. Greenwald, A. Pendri, and D. Bolikal,J. Org. Chem.,60(2), 331–336 (1995).

    Google Scholar 

  28. R. G. G. Leenders, K. A. A. Gerrits, R. Ruijtenbeek, et al.,Tetrahedron Lett.,36(10), 1701–1704 (1995).

    Google Scholar 

  29. D. E. Kerr,Cancer Res.,55(16), 3558–3563 (1995).

    Google Scholar 

  30. V. M. Vrudhula, H. P. Svensson, K. A. Kennedy, et al.,Bioconjugate Chem.,4(5), 334–340 (1993).

    Google Scholar 

  31. H. Okada, T. Koyanagi, and N. Yamada,Chem. Pharm. Bull.,42(1), 57–61 (1994).

    Google Scholar 

  32. C. J. Springer, I. Niculescu-Duvaz, and R. B. Pedley,J. Med. Chem.,37(15), 2361–2370 (1994).

    Google Scholar 

  33. K. A. Lamb, S. P. Denyer, F. D. Sanderson, et al.,J. Pharm. Pharmacol.,46, 965–973 (1994).

    Google Scholar 

  34. C. Clerici, G. Gentili, E. Boschetti, et al.,Digestive Diseases Sci.,39(12), 2601–2606 (1994).

    Google Scholar 

  35. S. De Lombaert, M. D. Erion, J. Tan, et al.,J. Med. Chem.,37(4), 498–511 (1994).

    Google Scholar 

  36. K. Watanabe, H. Hayashi, and Y. Mori,Pharmacol. Res.,28(1), 59–70 (1993).

    Google Scholar 

  37. S. De Lombaert, L. Blanchard, C. Berry, et al.,Bioorg. Med. Chem. Lett.,5(2), 151–154 (1995).

    Google Scholar 

  38. G. K. E. Scriba, D. M. Lambert, and J. H. Poupaert,J. Pharm. Pharmacol.,47, 197–203 (1995).

    Google Scholar 

  39. G. K. E. Scriba,Arch. Pharm.,326(8), 477–481 (1993).

    Google Scholar 

  40. H. T. Nagasawa, S. P. Kawle, J. A. Elberling, et al.,J. Med. Chem.,38(11), 1865–1871 (1995).

    Google Scholar 

  41. A. Nudelman and R. Keiner,Arch. Pharm. 326(11), 907–909 (1993).

    Google Scholar 

  42. S. Ahmed, T. Imai, and M. Otagiri,J. Pharm. Sci.,84(7), 877–883 (1995).

    Google Scholar 

  43. C. Meier, L. Habel, W. Laux, et al.,Nucleosides Nucleotides,14(3–5), 759–762 (1995).

    Google Scholar 

  44. G. R. Pettit, S. Freeman, M. J. Simpson, et al.,Anti-Cancer Drug Design,10(3), 243–250 (1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia

    Yu. V. Borodina, D. A. Filimonov & V. V. Poroikov

Authors
  1. Yu. V. Borodina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. A. Filimonov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. V. Poroikov
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was partly supported by the State Scientific-Technological Program “Creation of New Drugs by Methods of Chemical and Biological Synthesis,” Direction 04 “Computer Design of New Drugs,” Project 04.02.13.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borodina, Y.V., Filimonov, D.A. & Poroikov, V.V. Computer-aided prediction of prodrug activity using the pass system. Pharm Chem J 30, 760–763 (1996). https://doi.org/10.1007/BF02218831

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02218831

Keywords

Search

Navigation